Development of a stable single-vial liposomal formulation for vincristine

Background: Vincristine is a potent therapeutic agent with well-defined activity against hematologic malignancies and solid tumors. It is a cell-cycle specific drug with concentration and exposure duration dependent activity. When used by liposomal delivery, it exhibits enhanced anti-tumor activity....

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Wenxue, Wu, Fan, Lee, Robert J, Lu, Weigen, Wang, Jianxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596348/
https://www.ncbi.nlm.nih.gov/pubmed/31296986
http://dx.doi.org/10.2147/IJN.S205276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596348/
https://www.ncbi.nlm.nih.gov/pubmed/31296986
http://dx.doi.org/10.2147/IJN.S205276

Ejemplares similares